MINNEAPOLIS--(BUSINESS WIRE)--Possis Medical, Inc. (NASDAQ:POSS), a developer, manufacturer and distributor of pioneering medical devices used in endovascular procedures, today announced the full market release of its new AngioJet® Ultra Thrombectomy System. The next-generation Ultra System, which was approved by the U.S. Food and Drug Administration (FDA) in December 2006 for blood clot removal (thrombectomy), is now available for sale to hospitals and physicians throughout the United States.
